Norplant® implants and cardiovascular disease

Archived Abstract of Former PSC Researcher

Petitti, Diana B., Trivellore Raghunathan, David S. Siscovick, Stephen Sidney, Stephen M. Schwartz, Charles P. Quesenberry, Bruce M. Psaty, Thomas D. Koepsell, an, et al. 1998. "Norplant® implants and cardiovascular disease." Contraception, 57(5): 361-362.

A 1995 publication on serious adverse events in users of Norplant® implants submitted to the Food and Drug Administration's MedWatch Spontaneous Reporting System reported 14 hospitalizations for stroke in Norplant users. This number was higher than expected. This is a report on the association of current use of Norplant implants with stroke and myocardial infarction (MI) based on a pooled analysis of data from two population-based, case-control studies conducted in the US. All data collection for these two studies occurred after approval of Norplant implants for marketing in the US in December 1990. The methods of the individual studies are detailed in prior publications.

Norplant® implants cardiovascular diseases cerebrovascular disease myocardial infarction

Browse | Search | Next

PSC In The News

RSS Feed icon

Shaefer comments on the Cares Act impact in negating hardship during COVID-19 pandemic

Heller comments on lasting safety benefit of youth employment programs

More News


Dean Yang's Combatting COVID-19 in Mozambique study releases Round 1 summary report

Help Establish Standard Data Collection Protocols for COVID-19 Research

More Highlights

Connect with PSC follow PSC on Twitter Like PSC on Facebook